Nearly a decade ago, numerous drug makers paid huge fines for various fraudulent practices, but a falloff that began a few years ago has since accelerated dramatically, according to an analysis by Public Citizen, the consumer advocacy group.

Pharmaceutical companies paid roughly $2.9 billion to settle 38 cases involving federal and state civil and criminal charges in 2016 and 2017. This was quite comparable to the $2.9 billion paid for 39 settlements covering the previous two-year period, but much less than the 117 settlements totaling $9.8 billion during 2012 and 2013.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • This is not a duplicate comment. The first comment involved an anti seizure drug. While the second comment deals with the Recent Discovery by Law Firms that a drug used to treat people in chemotherapy may have had negative effects. These are two separate comments-apparently the TRUTH hurts.

  • Perhaps the drug companies are paying fewer settlements. Unfortunately that does not mean that the drug companies have performed ANY MORE EFFICENTLY-THIS CAN BE PROVEN WITH LEGAL AND MEDICAL RECORDS. The use of a generic substitute for the Brand Name Depakote Extended Relief resulted in the PERMANENT DESTRUCTION OF MY PREVIOUSLY ESTABLISHED SEIZURE CONTROL AND THE RESULTING OF SLEEP SEIZURES WHICH I HAD NEVER HAD BEFORE. Then the drug which was used for chemotherapy treatments had long lasting side effects which-the cancer doctor, the radiologist, the primary care doctor, the neurologist, and the beautician were unable to explain. The use of this drug during chemotherapy treatments caused all my hair to fall out in back but the effect on the sides was minimal; when the treatments ended the hair grew back faster and thicker in back than on the sides, now there is a Class Action Law Suit regarding the use of this drug. Drug firms may not be paying settlements; but that doesn’t mean that they haven’t made serious mistakes during the past ten years-they just haven’t been required to pay for them. Linda Ennis-A victim of Pharmacology’s negligence.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy